top of page

Novo builds heart failure case for semaglutide

BioPharma Dive staff

Sep 3, 2024

A pooled analysis of prior trial data showed semaglutide reduced the risk of heart failure worsening.

Read more here:https://www.biopharmadive.com/news/novo-semaglutide-heart-failure-ventyx-cfo-departure/725736/

bottom of page